Build an evidence record for a pharma pellets supplier. Assign responsibility for site confirmation, specification review, trial assessment and release decisions.
R
Rraynex Editorial Team
2 min read
Overview
Once a pharma pellets manufacturer is shortlisted, assign an owner to each qualification decision. Use a record that says what was requested, what arrived, who reviewed it, and which decisions the evidence supports. Procurement can track follow-up while QA and formulation retain responsibility for technical acceptance.
Identify the manufacturing and testing parties
Record the contracting seller and each proposed site separately. Ask who makes the core, applies the functional coating, tests the batch and releases the material. A company can be a direct manufacturer for one product and use an external operation for another. Ask who will notify the buyer about a relevant change in site, process or specification.
Define what is needed before a sample is approved
Sample qualification record
Owner
Evidence to record
Decision
Procurement
Seller, proposed quantity, expected delivery and point of contact
Confirm a commercially relevant evaluation request.
QA
Site identity, document revision, batch traceability and open evidence
Confirm evidence needed before receipt and trial.
Formulation
Intended dosage form, material specification and trial criteria
Approve the sample evaluation protocol.
Cross-functional team
Trial outcome, open deviations and owner for each item
Record whether to proceed and under what conditions.
Use the exact product reference in the record. A project using Rabeprazole EC Pellets may require review of acid-stage and later release data. Keep the sample's identifiers and test method with the results so the next reviewer can trace which material was assessed.
Can a sample pass while supplier approval is still open?
Yes. Record the technical outcome and the outstanding source or document checks separately. Agree which items must be closed before a commercial order.
How should buyers handle unavailable records?
Identify the specific decision that needs the record and ask which alternative evidence is available. Escalate items that affect the approved material or site.
Put insight into practice
Let’s discuss your next formulation project.
Share your product, strength, release requirements, expected quantity and destination market with our team.
Explore how international buyers can source pharmaceutical pellets and granules from India. Learn about supplier qualification, documentation, quality and export planning.